DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Celgene (NASDAQ: CELG)

124.04 1.00 (0.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $124.04 0.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $122.38
Previous Close $123.04
Daily Range $121.87 - $124.44
52-Week Range $83.16 - $140.72
Market Cap $98.1B
P/E Ratio 46.61
Dividend (Yield) $0.00 (0.0%)
Volume 4,598,003
Average Daily Volume 4,914,005
Current FY EPS $4.22




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Manic Markets: Healthcare Bargains Worth Buying

Industry Focus is sifting through the healthcare rubble to find your gems.

The Future Is ... OK; What You Can Trust, and What You Can't: Jim Cramer's Best Blogs

Jim Cramer’s 7 Lessons From the Stock Market’s Monumental Week

VUG, V, ORCL, CELG: ETF Inflow Alert

M&A Daily: Hedge Fund Hotels

Finally Oil Leads To A Rally - Cramer's Mad Money (8/27/15)

Kyle Bass's Latest IPR Missile Ventures Into Biologics And Threatens Amgen's $5B Enbrel Drug

Comments On The Market Correction; Focus On Biotechs: Large Caps

10 Reasons Why It's So Easy to Fall in Love With Celgene

A handy list of 10 reasons why Celgene may be at the head of the class in a very crowded biotech sector.

Short Sellers Become More Focused in Major Biotechs

See More CELG News...

CELG's Top Competitors

CELG $124.04 (0.81%)
Current stock: CELG
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB
AMGN $155.89 (0.11%)
Current stock: AMGN